Korea's Samsung Biologics Looks Strategically At PharmAbcine Deal
PharmAbcine Inc. ntered into a strategic partnership with Samsung Biologics for the development and manufacturing of PMC-403 pipeline, the next generation therapeutic antibody candidate to treat neovascular disorders. Samsung will.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
